SCHEMBL3282071

SCHEMBL3282071

CSc1ccc([S+]([O-])c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
PTGS2 P35354 2/20 0.40
CYP1A2 P05177 2/20 0.40
MEN1 O00255 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 5/20 0.39
LMNA P02545 1/20 0.38
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
KDM1A O60341 1/20 0.36
EGFR P00533 1/20 0.35
PDGFRB P09619 1/20 0.35
KDR P35968 1/20 0.35
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
SLC6A3 Q01959 3/20 0.34
CYP1A1 P04798 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2787957 0.91 ALDH1A1 (0.41) KMT2ACYP1A2MEN1ALDH1A1SLC6A2
SCHEMBL16641687 0.83 ALDH1A1 (0.44) KMT2APTGS2MEN1ALDH1A1LMNA
SCHEMBL12256916 0.82 KMT2A (0.42) KMT2APTGS2CYP1A2MEN1CYP3A4
SCHEMBL12336893 0.81 TDP1 (0.35) CYP3A4ALDH1A1LMNATSHR
SCHEMBL670781 0.80 KMT2A (0.41) KMT2APTGS2CYP1A2MEN1CYP3A4
SCHEMBL8089982 0.80 MAOA (0.43) CYP3A4ALDH1A1SLC6A4SMN1; SMN2TSHR
Bromide SCHEMBL3136632 0.80 KMT2A (0.41) KMT2APTGS2CYP1A2MEN1CYP3A4
Perchlorate SCHEMBL3136730 0.79 PTGS2 (0.38) KMT2APTGS2CYP1A2MEN1CYP3A4
(Phenylsulfinyl)Benzene SCHEMBL43199 0.78 TDP1 (0.37) CYP3A4ALDH1A1LMNASMN1; SMN2TSHR
SCHEMBL9443806 0.78 KMT2A (0.37) KMT2APTGS2CYP1A2MEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469604-B2 Method of manufacturing sulfonium salt TOYO GOSEI CO., LTD. (JP) 2016-10-18 US claimed
CN-118373784-B One-pot preparation method of 2-aryl benzoxazole and asymmetric sulfoxide 江苏师范大学 2024-09-03 CN disclosed
CN-118373784-A One-pot preparation method of 2-aryl benzoxazole and asymmetric sulfoxide 江苏师范大学 2024-07-23 CN disclosed
EP-3145910-B1 PIPERIDINE-BASED STABILIZERS AND POLYMERS END-CAPPED WITH THE SAME SOLVAY SPECIALTY POLYMERS USA (US) 2018-07-11 EP disclosed
US-9469604-B2 Method of manufacturing sulfonium salt TOYO GOSEI CO., LTD. (JP) 2016-10-18 US disclosed
US-20160068477-A1 METHOD OF MANUFACTURING SULTONIUM SALT TOYO GOSEI CO., LTD. (JP) 2016-03-10 US disclosed
US-7709548-B2 Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product SAN-APRO LIMITED (JP) 2010-05-04 US disclosed
US-20090163723-A1 METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE SAN-APRO LIMITED (JP) 2009-06-25 US disclosed
US-20080249270-A1 Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product DATE MASASHI 2008-10-09 US disclosed
EP-1953139-A1 METHOD FOR PRODUCING FLUORINATED SULFONIUM ALKYLFLUOROPHOSPHATE San-Apro Ltd. (JP) 2008-08-06 EP disclosed
US-7060858-B2 Method for manufacturing sulfonium salts SAN-APRO LIMITED (JP) 2006-06-13 US disclosed
EP-1640363-A1 PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING San-Apro Limited (JP) 2006-03-29 EP disclosed
US-20040030158-A1 Method for manufacturing sulfonium salts SAN-APRO LIMITED (JP) 2004-02-12 US disclosed
EP-1350789-A1 PROCESS FOR PRODUCING SULFONIUM SALT San-Apro Limited (JP) 2003-10-08 EP disclosed
US-6054501-A CURABILITY; GLOSSINESS; CAN BE BLENDED WITH INKS, PAINTS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2000-04-25 US disclosed
EP-0844255-A1 PHOTOPOLYMERIZATION INITIATOR AND ACTINIC RADIATION-CURABLE COMPOSITION COMPRISING THE SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1998-05-27 EP disclosed
EP-0629613-B1 Novel onium salt, photopolymerization initiator, energy ray-curing composition containing the initiator, and cured product NIPPON KAYAKU KK (JP) 1997-10-15 EP disclosed
US-5534557-A COATINGS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1996-07-09 US disclosed
US-5502083-A SULFONIUM CATALYST NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1996-03-26 US disclosed
EP-0629613-A2 Novel onium salt, photopolymerization initiator, energy ray-curing composition containing the initiator, and cured product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1994-12-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040030158-A1 Method for manufacturing sulfonium salts MLX, STS, SULT1A1 KMT2A 1947/4885PTGS2 1911/4885CYP1A2 80/4885
US-20090163723-A1 METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE ARSA, SCO2, DOHH KMT2A 4271/4885PTGS2 3580/4885CYP1A2 583/4885
US-20080249270-A1 Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product SPIN4, RPS6, SRM KMT2A 1558/4885PTGS2 3169/4885CYP1A2 4180/4885
US-20160068477-A1 METHOD OF MANUFACTURING SULTONIUM SALT STS, SULT1A1, ARSA KMT2A 1280/4885PTGS2 2281/4885CYP1A2 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.